Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation

[1]  S. Amini,et al.  Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[2]  Shyam Biswal,et al.  Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[3]  J. Vestbo,et al.  Increased T-regulatory cells within lymphocyte follicles in moderate COPD , 2009, European Respiratory Journal.

[4]  S. Hodge,et al.  Chemotactic Mediators of Th1 T-cell Trafficking in Smokers and COPD Patients , 2009, COPD.

[5]  J. Vestbo,et al.  COPD-related morbidity and mortality after smoking cessation: status of the evidence , 2008, European Respiratory Journal.

[6]  J. Blalock,et al.  Induction of lung emphysema is prevented by L‐arginine‐threonine‐arginine , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  I. Rahman,et al.  Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[8]  Nicola A Hanania,et al.  Pathogenesis of emphysema: from the bench to the bedside. , 2008, Proceedings of the American Thoracic Society.

[9]  A. Agustí,et al.  Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking , 2008, European Respiratory Journal.

[10]  R. Panos,et al.  Pulmonary hypertension associated with COPD , 2008, International journal of chronic obstructive pulmonary disease.

[11]  S. Hodge,et al.  Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects , 2007, Clinical and experimental immunology.

[12]  G. Joos,et al.  Cigarette smoke‐induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5‐deficient mice , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  I. Pavord,et al.  Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis , 2007, European Respiratory Journal.

[14]  A. M. Houghton,et al.  CD8+ T Cells Are Required for Inflammation and Destruction in Cigarette Smoke-Induced Emphysema in Mice1 , 2007, The Journal of Immunology.

[15]  G. Joos,et al.  Cigarette Smoke-Induced Pulmonary Inflammation and Emphysema Are Attenuated in CCR6-Deficient Mice1 , 2006, The Journal of Immunology.

[16]  J. Mauderly,et al.  Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  S. Ylä-Herttuala,et al.  Biology of vascular endothelial growth factors , 2006, FEBS letters.

[18]  D. Postma,et al.  Cigarette smoke-induced emphysema: A role for the B cell? , 2006, American journal of respiratory and critical care medicine.

[19]  A. Kraneveld,et al.  A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation , 2006, Nature Medicine.

[20]  D. Postma,et al.  Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers , 2005, European Respiratory Journal.

[21]  L. Wollin,et al.  Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. , 2005, American journal of respiratory and critical care medicine.

[22]  R. Pauwels,et al.  Time course of cigarette smoke-induced pulmonary inflammation in mice , 2005, European Respiratory Journal.

[23]  J. Marcus,et al.  Early changes of cardiac structure and function in COPD patients with mild hypoxemia. , 2005, Chest.

[24]  R. Egan,et al.  Role of CXCR2 in cigarette smoke-induced lung inflammation. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[25]  P. Sterk,et al.  Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[26]  P. Schmid‐Grendelmeier,et al.  Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective , 2005, Current opinion in pulmonary medicine.

[27]  M. Cosio,et al.  The development of emphysema in cigarette smoke-exposed mice is strain dependent. , 2004, American journal of respiratory and critical care medicine.

[28]  Tomoko Betsuyaku,et al.  Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. , 2004, American journal of respiratory cell and molecular biology.

[29]  C. Donner,et al.  Role of interleukin-8 in the pathogenesis and treatment of COPD. , 2004, Chest.

[30]  J. Hogg,et al.  Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.

[31]  M. Belvisi,et al.  New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease , 2004, Expert opinion on therapeutic targets.

[32]  M. Cosio.  Autoimmunity, T‐cells and STAT‐4 in the pathogenesis of chronic obstructive pulmonary disease , 2004, European Respiratory Journal.

[33]  J. Seagrave,et al.  EFFECTS OF CIGARETTE SMOKE EXPOSURE AND CESSATION ON INFLAMMATORY CELLS AND MATRIX METALLOPROTEINASE ACTIVITY IN MICE , 2004, Experimental lung research.

[34]  D. Mannino.  Chronic obstructive pulmonary disease: definition and epidemiology. , 2003, Respiratory care.

[35]  M. Cosio,et al.  Hypothesis: Does COPD have an autoimmune component? , 2003, Thorax.

[36]  WI de Boer,et al.  Potential new drugs for therapy of chronic obstructive pulmonary disease , 2003, Expert opinion on investigational drugs.

[37]  Josep Roca,et al.  Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[38]  V. Peinado,et al.  Pulmonary hypertension in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[39]  Jong-Suk Kim,et al.  Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. , 2003, The Journal of clinical investigation.

[40]  R. Tuder,et al.  The pathobiological mechanisms of emphysema models: what do they have in common? , 2003, Pulmonary pharmacology & therapeutics.

[41]  F. Sinigaglia,et al.  Chemokine receptors in inflammation: an overview. , 2003, Journal of immunological methods.

[42]  J. Van Damme,et al.  Macrophage inflammatory protein-1. , 2002, Cytokine & growth factor reviews.

[43]  Jin Dai,et al.  Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. , 2002, American journal of respiratory and critical care medicine.

[44]  P. Barnes,et al.  Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD , 2002, Thorax.

[45]  P. Jeffery.  Remodeling in asthma and chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.

[46]  D. Stewart,et al.  Cell-Based Gene Transfer of Vascular Endothelial Growth Factor Attenuates Monocrotaline-Induced Pulmonary Hypertension , 2001, Circulation.

[47]  A. Nissinen,et al.  Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study , 2001, Thorax.

[48]  P. Paré,et al.  Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.

[49]  K. Chung,et al.  Cytokines in chronic obstructive pulmonary disease , 2001, European Respiratory Journal.

[50]  L. Fabbri,et al.  Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[51]  P. Hirth,et al.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  S. Eddahibi,et al.  Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. , 2000, American journal of respiratory cell and molecular biology.

[53]  R. Stockley,et al.  Factors influencing airway inflammation in chronic obstructive pulmonary disease , 2000, Thorax.

[54]  E KoplanKate,et al.  Smoking Cessation , 2000 .

[55]  W. Bailey,et al.  Smoking Cessation and Lung Function in Mild-to-Moderate Chronic Obstructive Pulmonary Disease , 2000 .

[56]  Pauwels,et al.  Airway eosinophilia is not a requirement for allergen‐induced airway hyperresponsiveness , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[57]  A. Torres,et al.  Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[58]  R. Pardi,et al.  Upregulation of Integrin 6/β1 and Chemokine Receptor CCR1 by Interleukin-12 Promotes the Migration of Human Type 1 Helper T Cells , 1999 .

[59]  Dirkje S Postma,et al.  Ongoing airway inflammation in patients with COPD who do not currently smoke , 1999, Chest.

[60]  J. Pijoan,et al.  Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[61]  L. Fabbri,et al.  Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.

[62]  B. Balbi,et al.  Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. , 1998, The European respiratory journal.

[63]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[64]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[65]  P. Jeffery,et al.  Structural and inflammatory changes in COPD: a comparison with asthma. , 1998, Thorax.

[66]  M. Baggiolini,et al.  CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.

[67]  S. Romagnani,et al.  The Th1/Th2 paradigm. , 1997, Immunology today.

[68]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[69]  P. Zipfel,et al.  Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. , 1996, Journal of immunology.

[70]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[71]  L. Fabbri,et al.  Effect of smoking cessation on airway inflammation in chronic bronchitis. , 1995, American journal of respiratory and critical care medicine.

[72]  W M Thurlbeck,et al.  Emphysema: definition, imaging, and quantification. , 1994, AJR. American journal of roentgenology.

[73]  J. Wright,et al.  Effect of smoking cessation on pulmonary and cardiovascular function and structure: analysis of guinea pig model. , 1994, Journal of applied physiology.

[74]  A. Buist,et al.  The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.

[75]  C. Sköld,et al.  Smoking cessation rapidly reduces cell recovery in bronchoalveolar lavage fluid, while alveolar macrophage fluorescence remains high. , 1992, Chest.

[76]  G. Swan,et al.  Reversibility of airways injury over a 12-month period following smoking cessation. , 1992, Chest.

[77]  W. Thurlbeck,et al.  The effect of age on lung structure in male BALB/cNNia inbred mice. , 1984, The American journal of anatomy.

[78]  W. Thurlbeck,et al.  Postnatal growth of the mouse lung. , 1975, Journal of anatomy.

[79]  Brody Ar,et al.  Cytoplasmic inclusions in pulmonary macrophages of cigarette smokers. , 1975 .

[80]  D. Niewoehner,et al.  Pathologic changes in the peripheral airways of young cigarette smokers. , 1974, The New England journal of medicine.

[81]  Thurlbeck Wm.  Measurement of pulmonary emphysema. , 1967 .

[82]  R. Naeije.  Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.

[83]  Emiel F M Wouters,et al.  Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. , 2002, American journal of respiratory cell and molecular biology.

[84]  W. Bailey,et al.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. , 2000, American journal of respiratory and critical care medicine.

[85]  R. Pardi,et al.  Upregulation of integrin alpha6/beta1 and chemokine receptor CCR1 by interleukin-12 promotes the migration of human type 1 helper T cells. , 1999, Blood.

[86]  D. Hoffmann,et al.  Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke. , 1991, Critical reviews in toxicology.

[87]  A. Fishman.  Pulmonary Diseases and Disorders , 1980 .

[88]  A. Brody,et al.  Cytoplasmic inclusions in pulmonary macrophages of cigarette smokers. , 1975, Laboratory investigation; a journal of technical methods and pathology.

[89]  L. Reid,et al.  Right ventricular hypertrophy and its relationship to chronic bronchitis and emphysema. , 1974, British journal of diseases of the chest.

[90]  W. Thurlbeck.  Measurement of pulmonary emphysema. , 1967, The American review of respiratory disease.